These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 1569204

  • 1. IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency.
    Chaffee S, Mary A, Stiehm ER, Girault D, Fischer A, Hershfield MS.
    J Clin Invest; 1992 May; 89(5):1643-51. PubMed ID: 1569204
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: overview and case reports of three patients, including two now receiving gene therapy.
    Hershfield MS, Chaffee S, Sorensen RU.
    Pediatr Res; 1993 Jan; 33(1 Suppl):S42-7; discussion S47-8. PubMed ID: 8433874
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency.
    Bax BE, Bain MD, Fairbanks LD, Webster AD, Ind PW, Hershfield MS, Chalmers RA.
    Eur J Haematol; 2007 Oct; 79(4):338-48. PubMed ID: 17680812
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID).
    Chan B, Wara D, Bastian J, Hershfield MS, Bohnsack J, Azen CG, Parkman R, Weinberg K, Kohn DB.
    Clin Immunol; 2005 Nov; 117(2):133-43. PubMed ID: 16112907
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase.
    Hershfield MS, Buckley RH, Greenberg ML, Melton AL, Schiff R, Hatem C, Kurtzberg J, Markert ML, Kobayashi RH, Kobayashi AL.
    N Engl J Med; 1987 Mar 05; 316(10):589-96. PubMed ID: 3807953
    [Abstract] [Full Text] [Related]

  • 10. Enzyme replacement therapy of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase (PEG-ADA).
    Hershfield MS.
    Immunodeficiency; 1993 Mar 05; 4(1-4):93-7. PubMed ID: 8167743
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of adenosine deaminase deficiency with adenosine deaminase combined with polyethylene glycol].
    Girault D, Le Deist F, Debré M, Pérignon JL, Herbelin C, Griscelli C, Sciudery D, Hershfield M, Fischer A.
    Arch Fr Pediatr; 1992 Apr 05; 49(4):339-43. PubMed ID: 1497422
    [Abstract] [Full Text] [Related]

  • 12. PEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years.
    Hershfield MS.
    Clin Immunol Immunopathol; 1995 Sep 05; 76(3 Pt 2):S228-32. PubMed ID: 7554473
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency.
    Ochs HD, Buckley RH, Kobayashi RH, Kobayashi AL, Sorensen RU, Douglas SD, Hamilton BL, Hershfield MS.
    Blood; 1992 Sep 01; 80(5):1163-71. PubMed ID: 1387561
    [Abstract] [Full Text] [Related]

  • 16. Cerebral lymphoma in an adenosine deaminase-deficient patient with severe combined immunodeficiency receiving polyethylene glycol-conjugated adenosine deaminase.
    Kaufman DA, Hershfield MS, Bocchini JA, Moissidis IJ, Jeroudi M, Bahna SL.
    Pediatrics; 2005 Dec 01; 116(6):e876-9. PubMed ID: 16263974
    [Abstract] [Full Text] [Related]

  • 17. Adenosine deaminase: functional implications and different classes of inhibitors.
    Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, Camaioni E.
    Med Res Rev; 2001 Mar 01; 21(2):105-28. PubMed ID: 11223861
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycol-modified adenosine deaminase.
    Levy Y, Hershfield MS, Fernandez-Mejia C, Polmar SH, Scudiery D, Berger M, Sorensen RU.
    J Pediatr; 1988 Aug 01; 113(2):312-7. PubMed ID: 3260944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.